Akihito Tsuji Selected Research

Infections

2/2019

Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihito Tsuji Research Topics

Disease

60	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 07/2002
35	Neoplasms (Cancer) 01/2024 - 12/2003
33	Stomach Neoplasms (Stomach Cancer) 10/2023 - 12/2003
11	Neutropenia 12/2021 - 10/2012
6	Adenocarcinoma 10/2022 - 10/2012
6	Febrile Neutropenia 12/2021 - 10/2014
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2016
5	Disease Progression 11/2021 - 08/2012
5	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2002
5	Diarrhea 07/2020 - 02/2015
4	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 06/2014
4	Hepatocellular Carcinoma (Hepatoma) 04/2020 - 03/2003
3	Esophageal Neoplasms (Esophageal Cancer) 04/2024 - 02/2002
3	Colonic Neoplasms (Colon Cancer) 09/2022 - 06/2011
3	Fatigue 01/2022 - 01/2018
3	Carcinoma (Carcinomatosis) 11/2020 - 01/2005
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 12/2020
2	Esophageal Squamous Cell Carcinoma 10/2022 - 01/2021
2	Nausea 01/2022 - 01/2017
2	Anorexia 01/2018 - 01/2016
2	Anemia 01/2018 - 07/2016
2	Hypertension (High Blood Pressure) 04/2017 - 06/2015
2	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2017 - 01/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022
1	Fistula 02/2022
1	Hemorrhage 02/2022
1	Residual Neoplasm 11/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2020
1	Breast Neoplasms (Breast Cancer) 03/2019
1	Infections 02/2019

Drug/Important Bio-Agent (IBA)

32	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2022 - 09/2010
26	Irinotecan (Camptosar)FDA LinkGeneric 06/2023 - 09/2010
19	Cetuximab (Erbitux)FDA Link 06/2023 - 01/2012
19	Bevacizumab (Avastin)FDA Link 09/2022 - 06/2011
19	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 02/2002
16	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2002
9	trifluridine tipiracil drug combinationIBA 11/2021 - 10/2012
8	Leucovorin (Folinic Acid)FDA Link 01/2022 - 09/2010
8	regorafenibIBA 11/2021 - 06/2015
7	ErbB Receptors (EGF Receptor)IBA 05/2022 - 01/2016
7	Capecitabine (Xeloda)FDA Link 12/2021 - 01/2016
7	Gemcitabine FDA Link 01/2021 - 06/2014
7	PlatinumIBA 01/2021 - 02/2014
7	S-1 plus cisplatinIBA 09/2019 - 02/2014
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
6	Panitumumab (Vectibix)FDA Link 09/2022 - 08/2016
5	RamucirumabIBA 01/2023 - 04/2017
5	Circulating Tumor DNAIBA 01/2022 - 11/2020
4	pembrolizumabIBA 04/2024 - 01/2021
4	130-nm albumin-bound paclitaxelIBA 01/2023 - 07/2014
4	Monoclonal AntibodiesIBA 01/2022 - 06/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 06/2011
3	NivolumabIBA 10/2023 - 01/2019
3	TegafurIBA 01/2022 - 09/2010
3	XELOXIBA 09/2017 - 01/2016
2	Angiogenesis InhibitorsIBA 01/2024 - 05/2022
2	Albumin-Bound Paclitaxel FDA Link 01/2023 - 07/2014
2	UracilIBA 01/2022 - 02/2015
2	folfirinoxIBA 01/2022 - 01/2021
2	afliberceptIBA 11/2020 - 08/2018
2	AntibodiesIBA 11/2020 - 01/2012
2	human ERBB2 proteinIBA 10/2020 - 07/2014
2	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 02/2019
2	CreatinineIBA 01/2018 - 07/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2014 - 01/2011
1	binimetinibIBA 06/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2023
1	encorafenibIBA 06/2023
1	B7-H1 AntigenIBA 10/2022
1	Epidermal Growth Factor (EGF)IBA 09/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	resminostatIBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	fms-Like Tyrosine Kinase 3IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 11/2020
1	tributyl phosphate (TBP)IBA 10/2020
1	Cell-Free Nucleic AcidsIBA 10/2020
1	Trastuzumab (Herceptin)FDA Link 10/2020
1	Tyrosine Kinase InhibitorsIBA 04/2020
1	2-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA 03/2019
1	Immunoglobulin G (IgG)IBA 02/2019
1	AntigensIBA 02/2019
1	avelumabIBA 02/2019
1	MicellesIBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	thymidine kinase 1IBA 12/2018
1	taxaneIBA 11/2018
1	InterferonsIBA 08/2018

Therapy/Procedure

56	Drug Therapy (Chemotherapy) 04/2024 - 07/2002
41	Therapeutics 01/2024 - 02/2002
11	Adjuvant Chemotherapy 01/2021 - 02/2002
9	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 03/2003
4	Neoadjuvant Therapy 01/2022 - 01/2005
4	Hepatectomy 01/2021 - 06/2014
2	Glycemic Control 01/2024 - 01/2024
2	Gastrectomy 11/2020 - 01/2017
1	Endoscopes 05/2023
1	Surgical Instruments (Clip) 02/2022
1	Drug Tapering 12/2020
1	Operative Surgical Procedures 05/2019